A San Diego medical technology company received FDA approval this morning for a device that could transform how patients get blood tests done.<\/p>\n
The FDA approved Truvian’s new Tru-Verus machine, which can run nearly three dozen common blood tests right in a doctor’s office. The approval means patients won’t have to make separate appointments at labs and can receive results in minutes rather than days.<\/p>\n
San Diego company gets FDA approval for new blood testing machine<\/p>\n
The device allows patients to discuss their test results with their doctor immediately during their appointment, eliminating the need for follow-up visits or waiting for email notifications.<\/p>\n
“People don’t regularly go get their blood tests done because it’s inconvenient and it’s not accessible and it costs money, and so we’ve been working to bring down all of those barriers through this technology, and through the technology, we can now democratize blood testing,” Truvian founder Dena Marrinucci said.<\/p>\n
ABC 10News has followed Truvian since the company broke ground on their headquarters at UTC in 2019. The company submitted the Tru-Verus for FDA approval in 2024, marking a decade-long journey from startup to approved medical device.<\/p>\n
Truvian represents a true San Diego success story, with their first investor, most founders, and many employees based locally in the region.<\/p>\n
This story was reported on-air by a journalist and has been converted to this platform with the assistance of AI. Our editorial team verifies all reporting on all platforms for fairness and accuracy.<\/b><\/p>\n","protected":false},"excerpt":{"rendered":"A San Diego medical technology company received FDA approval this morning for a device that could transform how…\n","protected":false},"author":3,"featured_media":419776,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5134],"tags":[5229,1582,276,25997,196378,50,3549,7264,196377,196379,67,586,132,5230,68,2969],"class_list":{"0":"post-419775","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-san-diego","8":"tag-america","9":"tag-ca","10":"tag-california","11":"tag-fda-approval","12":"tag-new-blood-testing-device","13":"tag-news","14":"tag-san-diego","15":"tag-sandiego","16":"tag-tru-verus","17":"tag-truvian","18":"tag-united-states","19":"tag-united-states-of-america","20":"tag-unitedstates","21":"tag-unitedstatesofamerica","22":"tag-us","23":"tag-usa"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115650716317190270","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/419775","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=419775"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/419775\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/419776"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=419775"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=419775"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=419775"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}